Thus, TGF-β displays a tumor suppressor phenotype in normal cells and early stages of tumorigenesis, whereas in the later stages of cancer progression, it functions as proto-oncogene and promotes oncogenesis. This evidence concerns the gene TGFB1 and neoplasm.